Acitretin to be sold only on prescription of Registered Medical Practitioner
Due to the highly teratogenic impact of the psoriasis medicine Acitretin, the Ministry of Health and Family Welfare has placed it on schedule H of the Drugs and Cosmetics Rules, 1945, limiting it to be marketed only on the prescription of a Registered Medical Practitioner. The said policy will take effect from November 2022.
In India, Schedule H refers to a group of prescription drugs that are listed as an appendix to the Drugs and Cosmetics Rules, 1945, which were introduced in 1945. There are medications that can only be purchased with a qualified doctor's prescription and can not be purchased over-the-counter.
For more details, check out the full story on the link below:
By Prescription only: Psoriasis drug Acitretin to be included Schedule H of Drugs Rules 1945
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.